Endothelial Dysfunction and SARS-CoV-2 Infection: Association and Therapeutic Strategies
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome-coronavirus 2 (SARS-CoV-2), has been recently considered a systemic disorder leading to the procoagulant state. Preliminary studies have shown that SARS-CoV-2 can infect endothelial cells, and extensive evidence of infl...
Main Authors: | Hai Deng, Ting-Xuan Tang, Deng Chen, Liang-Sheng Tang, Xiang-Ping Yang, Zhao-Hui Tang |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | Pathogens |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-0817/10/5/582 |
Similar Items
-
Understanding COVID-19-associated endothelial dysfunction: role of PIEZO1 as a potential therapeutic target
by: Xiaoting Zhang, et al.
Published: (2024-02-01) -
Endothelial Dysfunction in SARS-CoV-2 Infection
by: Francesco Nappi, et al.
Published: (2022-03-01) -
The vascular endothelium: the cornerstone of organ dysfunction in severe SARS-CoV-2 infection
by: Stéphanie Pons, et al.
Published: (2020-06-01) -
Stroke in a young adult with mild COVID-19 suggesting endotheliitis
by: S. Crippa, et al.
Published: (2020-11-01) -
Endothelial cell dysfunction and targeted therapeutic drugs in sepsis
by: Kunwei Chen, et al.
Published: (2024-07-01)